the efficiency of using α-glucosidase inhibitors in patients with diabetes mellitus type 2 and obesity
Clicks: 309
ID: 186312
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
309 views
62 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #17 of 79 articles by views in Macromolecular rapid communications
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The article presents the results of studying the impact of α-glucosidase inhibitors on body weight and main carbohydrate metabolism indicators. The authors note the positive effects of drugs from this group on all components of metabolic syndrome, safety for the body, absence of serious contraindications and low level of hypoglycemia. Voglibose as representative of α-glucosidase inhibitors can be effectively used in combination with metformin, as well as together with insulin therapy.
| Reference Key |
pasiechko2015mnarodnijthe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;N.V. Pasiechko;H.Ya. Loi;L.P. Mazur;I.P. Savchenko |
| Journal | Macromolecular rapid communications |
| Year | 2015 |
| DOI |
10.22141/2224-0721.2.66.2015.75444
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.